These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30285700)

  • 1. CRISPR/Cas9-mediated genome editing induces gene knockdown by altering the pre-mRNA splicing in mice.
    Tang JX; Chen D; Deng SL; Li J; Li Y; Fu Z; Wang XX; Zhang Y; Chen SR; Liu YX
    BMC Biotechnol; 2018 Oct; 18(1):61. PubMed ID: 30285700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated genome editing induces exon skipping by complete or stochastic altering splicing in the migratory locust.
    Chen D; Tang JX; Li B; Hou L; Wang X; Kang L
    BMC Biotechnol; 2018 Sep; 18(1):60. PubMed ID: 30253761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
    Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
    Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
    Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
    Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random Splicing of Several Exons Caused by a Single Base Change in the Target Exon of CRISPR/Cas9 Mediated Gene Knockout.
    Kapahnke M; Banning A; Tikkanen R
    Cells; 2016 Dec; 5(4):. PubMed ID: 27983621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient somatic and germline genome engineering of Bactrocera dorsalis by the CRISPR/Cas9 system.
    Zhao S; Xing Z; Liu Z; Liu Y; Liu X; Chen Z; Li J; Yan R
    Pest Manag Sci; 2019 Jul; 75(7):1921-1932. PubMed ID: 30565410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
    Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
    Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progresses in CRISPR genome editing in plants].
    Li H; Xie K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation of DMD Muscle Cell Model Using CRISPR-Cas9 Genome Editing to Test the Efficacy of Antisense-Mediated Exon Skipping.
    Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1828():165-171. PubMed ID: 30171541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
    Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex CRISPR Mutagenesis of the Serine/Arginine-Rich (SR) Gene Family in Rice.
    Butt H; Piatek A; Li L; S N Reddy A; M Mahfouz M
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31394891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-induced exon skipping is dependent on premature termination codon mutations.
    Sui T; Song Y; Liu Z; Chen M; Deng J; Xu Y; Lai L; Li Z
    Genome Biol; 2018 Oct; 19(1):164. PubMed ID: 30333044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.